97%Confidence
0Views
FDASource
2026-03-16Date
Summary
The final Wizcure recall for another advanced dry eye formula solidifies a major quality crisis at the manufacturer, affecting multiple distributors and product types. This creates a market opportunity for competitors in the dry eye treatment segment.
Actionable: Capitalize on the market gap by promoting alternative, reliably manufactured dry eye relief products.
AI Confidence: 97%
Data Points
firmWizcure Pharmaa Private Limited
classificationClass II
statusOngoing
distributionDistributed Nationwide in the USA
productVista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing Formula, 10 ml (1/3 fl.oz.), Wizcure Pharmaa PVT. LTD., H-8
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now